"MUSC Health is no longer seeing patients at this facility."

During the past decade, Hollings Cancer Center at Medical University of South Carolina conducted 71 clinical trials. In the 10-year time frame, 71 clinical trials started and 116 clinical trials were completed, i.e. on average, 163.4% percent of trials that started reached the finish line to date. In the past 5 years, 25 clinical trials started and 38 clinical trials were completed. i.e. 152% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hollings Cancer Center at Medical University of South Carolina" #1 sponsor was "SWOG Cancer Research Network" with 44 trials, followed by "Children's Oncology Group" with 42 trials sponsored, "Radiation Therapy Oncology Group" with 21 trials sponsored, "Medical University of South Carolina" with 17 trials sponsored and "Pfizer" with 17 trials sponsored. Other sponsors include 161 different institutions and companies that sponsored additional 102 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hollings Cancer Center at Medical University of South Carolina" #1 collaborator was "National Cancer Institute (NCI)" with 143 trials as a collaborator, "NRG Oncology" with 13 trials as a collaborator, "Cancer and Leukemia Group B" with 10 trials as a collaborator, "Merck Sharp & Dohme LLC" with 8 trials as a collaborator and "SWOG Cancer Research Network" with 6 trials as a collaborator. Other collaborators include 74 different institutions and companies that were collaborators in the rest 61 trials.

According to Clinical.Site data, the most researched conditions in "Hollings Cancer Center at Medical University of South Carolina" are "Leukemia" (30 trials), "Lung Cancer" (22 trials), "Breast Cancer" (21 trials), "Prostate Cancer" (20 trials) and "Head and Neck Cancer" (14 trials). Many other conditions were trialed in "Hollings Cancer Center at Medical University of South Carolina" in a lesser frequency.

Most popular intervention types in "Hollings Cancer Center at Medical University of South Carolina" are "Drug" (258 trials), "Radiation" (62 trials), "Biological" (56 trials), "Procedure" (42 trials) and "Other" (30 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (36 trials), "Placebo" (27 trials), "cyclophosphamide" (25 trials), "etoposide" (21 trials) and "filgrastim" (21 trials). Other intervention names were less common.

The vast majority of trials in "Hollings Cancer Center at Medical University of South Carolina" are 261 trials for "All" genders, 20 trials for "Female" genders and 20 trials for "Male" genders.

Currently, there are NaN active trials in "Hollings Cancer Center at Medical University of South Carolina". undefined are not yet recruiting, 15 are recruiting, 27 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 199 completed trials in Hollings Cancer Center at Medical University of South Carolina, undefined suspended trials, and 47 terminated clinical trials to date.

Out of the total trials that were conducted in Hollings Cancer Center at Medical University of South Carolina, 41 "Phase 1" clinical trials were conducted, 139 "Phase 2" clinical trials and 110 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 11 trials that are defined as “Not Applicable".